Previous close | 21.29 |
Open | 21.25 |
Bid | 20.52 x 200 |
Ask | 20.60 x 100 |
Day's range | 20.44 - 21.69 |
52-week range | 20.42 - 79.65 |
Volume | |
Avg. volume | 663,598 |
Market cap | 1.104B |
Beta (5Y monthly) | 0.24 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DUBLIN, April 15, 2024--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.
DUBLIN, March 05, 2024--Prothena today announced that members of its senior management team will participate in two upcoming investor conferences in March.
DUBLIN, March 04, 2024--Prothena today announced that it has named David Ford to a newly created position of Chief People Officer.